Deaths associated with ivermectin treatment of scabies [3]

Lancet

Volumn 349, Issue 9059, 1997, Pages 1144-1145

  Barkwell, Robert ^a,b   Shields, Suzanne ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b Wentworth Lodge   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CROTAMITON; IVERMECTIN; LINDANE; PERMETHRIN;

ANOREXIA; CONTROLLED STUDY; DEATH; HUMAN; LETHARGY; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCABIES;

EID: 0030934256     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63020-6     Document Type: Article

References (4)

1. Brown KR, Neu DC. Ivermectin: clinical trials and treatment schedules in onchocerciasis. Acta Leidensia 1990; 59: 169-75.
2. Goa KL, McTavish D, Clissold SP. Ivermectin: a review of its antifilarial activity, pharmacological properties, and clinical efficacy in onchoceriasis. Drugs 1990; 42: 640-58.
3. Glazion P, Cartel JL, Alzieu P, et al. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop Med Parasitol 1993; 44: 331-32.
4. Meinking TL, Taplin D, Hermida J, Pardo R, Kendel F. The treatment of scabies with ivermectin. N Engl J Med 1996; 333: 26-30.